Statement from Richard Besser, MD, on FDA Granting Full Approval to the Pfizer/BioNTech COVID-19 Vaccine for Individuals Ages 16 and Older

The FDA’s decision to grant full approval of the Pfizer/BioNTech COVID-19 vaccine is grounded in science and the real-world experience of administering hundreds of millions of vaccine doses in the United States.

Recommend0 recommendationsPublished in national-health-sources

Related Articles

What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5

Big news for Latino parents – the Moderna and the Pfizer-BioNTech COVID-19 vaccines have been authorized for children between ages 6 months and 5 years. The CDC now recommends everyone 6 months or older to get vaccinated against COVID-19. Those 5 years of age and older are also recommended to get a COVID-19 vaccine booster, …
The post What Latino Parents Should Know: COVID-19 Vaccinations Authorized for Children Under 5 appeared first on Salud America.

FDA’s Big Plan to Enhance Public Health in 2025

The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.

What Latino Parents Should Know: COVID-19 Vaccine Available to 12 to 15-Year-Olds

Good news! Children ages 12 to 15 can now get a COVID-19 vaccine! On May 10, 2021, the FDA authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use for children ages 12 to 15. It had previously been approved for those ages 16 and older. This next step in reaching herd immunity is crucial. Not only …
The post What Latino Parents Should Know: COVID-19 Vaccine Available to 12 to 15-Year-Olds appeared first on Salud America.

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

Study: Most Black and Latino Adults Hesitant to Take a COVID-19 Vaccine

As we grow closer to developing a COVID-19 vaccine, some uncertainty lies ahead. Several new studies show that older Americans, especially Latino and Black adults, are skeptical of the safety and efficacy of a COVID-19 vaccine. The results indicate mistrust between communities of color and public health officials, likely due to historical racism in health …
The post Study: Most Black and Latino Adults Hesitant to Take a COVID-19 Vaccine appeared first on Salud America.